Diuretics and Volume Overload in Early CKD

NCT05171686 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

49

Enrollment

FED

Sponsor class

Conditions

Chronic Kidney Disease
Hypertension

Interventions

DRUG: Diuretic augmentation (hydrochlorothiazide, chlorthalidone, furosemide, torsemide, or bumetanide)

Sponsor

VA Office of Research and Development